Post-Menopausal Hormone Therapy Improving the Risk Benefit Ratio With Ultra-Low Doses of Estrogen

US Endocrinology - United Kingdom
doi 10.17925/use.2007.00.1.77
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Evolution of Menopausal Hormone Therapy: From Standard to Ultra-Low Doses

Medical Council
2016English

Menopausal Hormone Therapy and Risk of Clinical Breast Cancer Subtypes

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Hormone Therapy for Menopausal Symptoms

Clinical Nurse Specialist
ManagementLPNLeadershipAdvancedDiagnosisLVNAssessmentSpecialized Nursing
2004English

Hormone Therapy for Menopausal Symptoms

BMJ
2012English

Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Availability of Menopausal Hormone Therapy Products Worldwide

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2020English

Menopausal Hormone Therapy: Modern State of the Problem

Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini
2019English

Menopausal Hormone Therapy and Breast Cancer: What Is the True Size of the Increased Risk?

British Journal of Cancer
Cancer ResearchOncology
2016English

Epithelial Proliferation and Hormone Receptor Status in the Normal Post-Menopausal Breast and the Effects of Hormone Replacement Therapy

British Journal of Cancer
Cancer ResearchOncology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy